|
|
|||||||||||
The British Journal of Psychiatry 153: 650-658 (1988)
© 1988 The Royal College of Psychiatrists
I Marks and G O'Sullivan
Institute of Psychiatry, London.
In the short term, both antidepressants and exposure therapy usually improve agoraphobia/panic (AP) and obsessive-compulsive (OC) disorders and are accepted by most patients; psychological methods omitting exposure are not consistently helpful. Antidepressants have a broad- spectrum rather than specific anti-agoraphobia/panic or anti-obsessive- compulsive action. For long-term efficacy, there is good evidence for the value of exposure, but none for drugs. Because of relapse on ceasing drugs, and their side-effects, medication is less useful as the first line of treatment for chronic agoraphobia/panic or obsessive- compulsive disorder than is the lastingly helpful approach of exposure. Antidepressants are worth trying when patients refuse or fail with exposure therapy, or are dysphoric.
This article has been cited by other articles:
![]() |
R. Morriss, L. Gask, C. Smith, and L. Battersby Training practice nurses to assess and manage anxiety disorders: A pilot study Journal of Research in Nursing, March 1, 1999; 4(2): 132 - 142. [Abstract] [PDF] |
||||
![]() |
A. J. Bond Commentary on 'Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation?' J Psychopharmacol, January 1, 1991; 5(4): 288 - 289. [PDF] |
||||
![]() |
M. J. Telch Beyond sterile debate J Psychopharmacol, January 1, 1991; 5(4): 296 - 298. [PDF] |
||||
![]() |
D. T. Healy The psychopharmacological era: notes toward a history J Psychopharmacol, January 1, 1990; 4(3): 152 - 167. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |